At Qcil, we believe that health isn't merely the absence of illness, but the vibrant pursuit of life's possibilities. In Africa, vitality and resilience are virtues we celebrate – which is why for us, it's not about surviving, it's about thriving. This is what makes us more than just medication manufacturers. We embody the spirit of living vigorously – at the heart of our commitment to scientific innovation and true wellness, captured in our mantra, "Life After Well”.
To become a center of excellence in the manufacturing of quality affordable and newer medicines.
To provide affordable and efficacious medicines in a sustainable way, in order to improve the quality of life.
Qcil's plant has been designed to meet the world’s most stringent regulatory standards.
In September 2018, following a successful Initial Public Offering, Qcil shares were listed on the Uganda Securities Exchange.
Quality Excellence Accountability Teamwork Integrity Customer Focus Innovation
At Qcil we are dedicated to producing high-quality, affordable, life-saving medicines because we believe Africans deserve to live long and healthy lives. We envision a future where good health is the norm for all, not just a privileged few. This is why we are committed to ensuring that no one is denied access to essential medications. Our mission extends beyond medicine, we are committed to making a meaningful difference.
Qcil is committed to producing high-quality, affordable medicines that is easily accessible to meet the growing demands of Africa's increasing population. Beyond treating malaria, HIV, and Hepatitis B, Qcil is also pioneering innovative treatments that will manage the surge of non-communicable diseases (NCDs) and cancer. Following a successful Initial Public Offering in September 2018, Qcil shares were listed on the Uganda Securities Exchange for the first time.
Qcil employs over 350 permanent staff, with 38% being female. As an equal opportunity employer, we do not discriminate based on gender, age, disability, ethnicity, religion, or nationality. We take great pride in the quality of our employees by giving them access to development opportunities, training and empowering them to be innovative and enhancing their ability to deliver the best results for both our business and Africans.
As a founding Chief Executive Officer of Cipla Quality Chemical Industries Limited, Mr Katongole was promoted to the position of Executive Chairman in November 2013. Previously, Emmanuel served as Managing Director and Shareholder of Quality Chemicals Industries Limited (the local firm that partnered with Cipla to form CiplaQcil). He has a wealth of experience in senior management and business entrepreneurship.
Emmanuel holds a Master of Arts Degree in Economic Policy and Planning and a Bachelor of Statistics Degree, both from Makerere University. Married, with 4 children, he enjoys reading, swimming and playing chess.
Emmanuel is also the founder of Vero Food Industries – a food and beverage company; a Shareholder and Director in Tinosoft Ltd – a leading IT firm; and is a member of the Initiative for Global Development (Frontier 100) – a group that joins the most successful business leaders operating in frontier markets. He is Chairman of the Uganda National Oil Company; Chairman of Mauritius Union Assurance (U) Ltd and Chairman of the Advisory Board of London-based TLG Capital Ltd. He has won several business awards, besides getting numerous nominations.
In April 2020, he was appointed by His Excellency, the President of Uganda, to chair the National Response Fund on Covid-19 Taskforce in Uganda. In February 2021, he was installed as the 5th Chancellor of Nkumba University in Uganda and was appointed as a Papal Knight by Pope Francis in June 2021.
He was the East African winner and representative at the 2013 Ernst and Young World Entrepreneur of the Year Awards in Monte Carlo; bagged the 2012 Africa Business Leadership and the Africa Entrepreneurship Awards and was a finalist for the East Africa Ernst and Young Entrepreneur of the Year 2011 Awards. He is a Rotarian, who has steadily and diligently served his Rotary Club of Muyenga as Director; President; Country Chairperson for Annual Giving; Assistant Governor; Chairperson of the 2010/11 District Conference and is now the District Governor for Rotary district 9211, which comprises of Tanzania and Uganda.
Mr Mutebi is a Ugandan entrepreneur, industrialist and philanthropist, with specific experience in pharmaceutical manufacturing and Real Estate development.
He holds a BSc in Accounting and Finance from the University of Buckingham, and a Bsc in Physics and Mathematics from Makerere University.
He has extensive experience in financial planning and management; economic policy; investment management and corporate governance, which will be of great value and an addition to the Company.
Mr Baguma is a founding Director and was also the founding Chief Commercial Officer at Cipla Quality Chemicals Industries Ltd from 2000 to 2005.
George is a former Deputy Commissioner at the Directorate of Animal Resources in the Ministry of Agriculture, Animal Industries and Fisheries in Uganda. Mr Baguma has a Degree and Postgraduate Diploma from Makerere University and a Master’s from Imperial College London.
Mr Pal was appointed CEO in September 2021.
Prior to his appointment, he served as Chief Operating Officer from March 2020. Before joining the Company, he served as Senior Director - Head of Manufacturing of Cipla South Africa and Head of Manufacturing and Master Coach in Cipla India.
Mr Pal has an MBA from Nelson Mandela University Business School in South Africa. With 15 years’ experience in core operations, Mr Pal has specialised in building strong teams and running successful pharmaceutical operations in the last 5 years. Mr Pal has strong leadership and people management skills, along with strong strategic skills.
Mrs Mandel is a Co-founder and Managing Partner of Africa Capitalworks and Capitalworks Investment Management, a position she has held for 16 years. She has also previously held positions as a Managing Director and Country Head, SSA; Founding Director of RMB Morgan Stanley and General Manager of Johannesburg Consolidated Investment Company.
She holds a Master of Science in Development Economics from New College, Oxford University (Marshall Scholar) and a Bachelor of Science with high honours in Business Administration (Production Management).
She brings extensive experience in corporate finance; M&A; strategy and execution; and equity and investment management in Sub-Saharan Africa.
Joseph is a Fellow of the Association of Chartered Certified Accountants (FCCA); a Member of the Institute of Certified Public Accountants of Uganda (CPA); and a Founder Council Member of both the Institute of Certified Public Accountants of Uganda and the Zambia Institute of Chartered Accountants (ZICA).
Mr Baliddawa is a former partner of PricewaterhouseCoopers Africa (“PwC”), having spent 34 years with PwC in a variety of roles in the UK; Zambia and Uganda. He is also a former Country Senior Partner of PWC Uganda.
He is a former President of the Institute of Corporate Governance of Uganda and is currently an Honorary Member of the same Institute. He is a Board Member and Chair of the Audit Committees of NCBA Bank; Alliance Africa General Insurance Ltd and CiplaQcil. He recently served as a non-Board Member of the Audit Committee of Vision Group for 9 years.
He is Chair of the Uganda-Norway Friendship Association; a former President of the Lions Club of Kampala; and currently a member of the International Association of the Lions Clubs. He is also a former Council Member and Chairman of the Audit Committee of Uganda Martyrs University.
Joseph has extensive experience in management and leadership, having served in PwC’s country management; formulation and monitoring of the implementation of strategic growth plan for Africa; risk; quality and compliance standards management and financial reporting.
He has received many national and international awards from World Bank, national and international accountancy organisations and the International Association of Lions Clubs.
Mr Baliddawa brings to the Board extensive experience in financial management and reporting; internal and external audit; risk management; compliance and governance.
He currently serves as Chair of the Board Audit and Risk Committee and is a member of the Nomination and Remuneration Committee.
Prof. Mugyenyi is a holder of a Bachelor of Medicine and Surgery (MB ChB); Fellow of the Royal College of Physicians of Ireland (FRCPI); Fellow of the Royal College of Physicians (Edinburgh) (FRCP Edin) and Doctor of Science (ScD(h)).
He is a Paediatrician; Researcher and Specialist on HIV/AIDS and related conditions.
Until his retirement, he was the Executive Director of Joint Clinical Research Centre.
He was among the pioneers who introduced the widespread use of affordable ARVs in Africa, as well as the development of an effective model of ARVs in Africa and the development of an effective model for scaling up ARVs in resource-limited countries.
He has been a Principal Investigator on dozens of landmark research projects funded by National Institutes of Health (NIH); European Union; WHO and Medical Research Council (MRC).
His research and publications cover a wide spectrum of HIV/AIDS, related diseases and other medical conditions.
He has served as a Board Member on several institutions and organisations in Africa; the UK; India and the USA.
Specific areas of his research include paediatric and adult trials; HIV resistance; HIV prevention; immunological studies, including HIV vaccine trails; pharmacokinetic, molecular and epidemiological studies, as well as social and economic impact of HIV.
He is the Chairperson of the Nominations and Remuneration Committee.
Mr Mwanje is the Chief Finance Officer of the National Social Security Fund (NSSF) and a Fellow of the Association of Chartered Certified Accountants (FCCA).
He holds a Master’s in Business Administration from Edinburg Business School - Herriot Watt University; a Postgraduate Diploma from the University of Leicester and a Postgraduate Diploma in Business Management from Uganda Management Institute. He also undertook the Strathmore Business School Executive Programme.
He has undertaken several short courses on leadership; risk management; finance management; performance management and corporate governance.
Previously, he served as the Head of Sales and Operations at NSSF; Head of Commercial Decision - Bank of Africa; Chief Accountant and Head of Internal Controls at Allied Bank International, Uganda.
He is a strategic leader, responsible for providing direction and managing performance. He is known for being a changemaker, with a history of structuring processes and building strong and motivated high-performance teams.
He is currently the Chairperson of the Board Audit Committee - Entrepreneurs Financial Centre (EFC) and serves on the Board of Kampala Club Limited. He is also a member of the Rotary Club - Kampala North.
He is a member of the Audit & Risk Committee of the Board.
Vusi Raseroka is an accomplished and highly experienced Private Equity Investment Professional, with over 30 years’ experience in financial services; corporate finance; financing and investments across the African Continent. He is passionate about investing in Africa and has directly transacted across multiple jurisdictions on the African Continent. He is an Unlisted Investments Specialist and Fund Manager, with extensive private equity; infrastructure and project finance (equity and debt) knowledge, skills and expertise.
Vusi is employed by the Public Investment Corporation SOC Limited as a Fund Principal in the unlisted Investments Division, where he heads the Developmental Investments Fund for Africa ex SA. Prior to this, he was a Portfolio Manager - Economic Infrastructure, and thereafter became an Associate Fund Principal and then a Fund Principal in the Private Equity division, all within the PIC. Prior to joining the PIC, he was employed by the Development Bank of Southern Africa, in their international Finance Division. Prior to joining the DBSA, he was the Head of Privatisation and Restructuring at the Public Enterprises Evaluation and Privatisation Agency in Botswana. Prior to this, he held various banking and corporate finance roles in Botswana.
Vusi has a strong background in deal origination; financial analysis and negotiation. He has successfully managed investment portfolios, mentored teams and achieved notable accomplishments in investing; restructuring loans; facilitating acquisitions and making equity investments. He has outstanding communication and negotiation skills, with an innovative approach to solution-finding, and strong analytic and critical reasoning ability. He demonstrates expertise in business development; deal origination and structuring; financial analysis; and modelling and negotiation.
Vusi holds a Bachelor of Commerce (B. Com) Degree in Accounting from the University of Botswana; is a Fellow of the Association of Chartered Certified Accountants (FCCA) (UK) and is a member of the Institute of Directors of Southern Africa.
Mr Pal was appointed CEO in September 2021.
Prior to his appointment, he served as Chief Operating Officer from March 2020. Before joining the Company, he served as Senior Director - Head of Manufacturing of Cipla South Africa and Head of Manufacturing and Master Coach in Cipla India.
Mr Pal has an MBA from Nelson Mandela University Business School in South Africa. With 15 years’ experience in core operations, Mr Pal has specialised in building strong teams and running successful pharmaceutical operations in the last 5 years. Mr Pal has strong leadership and people management skills, along with strong strategic skills.
Mr Kakooza joined CiplaQcil in March 2020 and oversees the finance; tax and ICT functions of the company. He was previously the Head of Finance at Kampala Pharmaceuticals 1996 Limited (KPI). Prior to working at KPI, Frederick was the Chief Finance Officer and Financial Management Expert at Energy Utility Corporation Limited, Rwanda’s national electricity distributor. He has also held senior roles at Umeme Limited; Warid Telecom Uganda Limited and MultiChoice Uganda Limited. Frederick started his career at Deloitte & Touche (Deloittes). Fred has over 20 years’ experience in Uganda and Rwanda, where he has built a strong background in strategic performance management and streamlining robust operations across the telecoms; utilities and manufacturing sectors.
He holds a Master of Business Administration Degree from Heriot-Watt University in the UK and a Bachelor of Science Degree in Economics and Statistics from Makerere University. He is a Fellow of the Association of Chartered Certified Accountants (FCCA); Fellow of Chartered Institute of Management Accountants (FCMA) and a Member of the Institutes of Certified Public Accountants of Kenya and Uganda.
Mr Vadepalli has been the Quality Assurance Manager at CiplaQcil since 2007. Prior to this, Mr Vadepalli worked for Cipla India in the Quality Assurance department as of 2002. He has over 17 years’ experience in pharmaceutical quality assurance and holds a Bachelor’s Degree in Pharmacy, from Pune University in India.
Dr Mbabazi has over 17 years’ experience in the pharmaceutical industry and holds a Bachelor of Pharmacy from Rajiv Gandhi University of Health Sciences (RGUHS), Bangalore India; IPAT certificate and MSc. BIRS from Purdue University, West Lafayette, USA, where she has continued to participate in Master’s and PhD programmes for Sustainable Medicines for Africa, since 2020.
With a cumulative work experience of 40 years, Dr Mbabazi brings regulatory and practical experience in business policy set up for Community Pharmacy, Hospital Pharmacy, vaccine manufacturing and pharmaceutical manufacturing.
She has worked as Pharmacist Director for Nabaw Pharmacy and HealthPlus Pharmacy; and as Consultant Pharmacist and eventually pioneering Hospital Pharmacist for the leading private health care service provider in Uganda Nakasero Hospital Limited.
She has worked as Manufacturing Consultant, Kisakye Industries, for the setup liquid orals; topical solutions and exploration of the tablet solid dosage form; and as Company/Production Pharmacist/ Manager Operations for Brentec Investments Limited, for the first locally manufactured and marketed vaccine.
She sits on the Pharmaceutical Society of Uganda (PSU) Committees that shape the Pharmacy Profession growth and regulation. She currently represents UPMA-Qcil on the National Steering Committee, for track and trace for Health/Pharmaceutical commodities.
Mr Kiggundu has been the Human Resources Manager at CiplaQcil since 2009. Prior to this, he worked for Uganda Breweries Limited, first as a brewer and then rose through the ranks to the level of Packaging Manager; Capability Development Manager and Human Resources Manager. Now with over 20 years’ experience, Mr Kiggundu holds a Bachelor of Science in Food Science and Technology from Makerere University; a Diploma in Brewing from Herriot Watt University in the UK; a Postgraduate Diploma in Human Resources and a Master’s Degree in Human Resources Management, both from the Uganda Management Institute (UMI).
Peace is a seasoned legal professional with a Bachelor of Laws Degree from Uganda Christian University, Mukono and an enrolled Advocate of the High Court of Uganda. With over 12 years’ experience in the legal field, she has honed her expertise in various aspects of compliance risk management; enterprise risk management and corporate legal advisory services.
Over the course of her career, she has specialised in developing and implementing compliance risk management programmes, tailored to meet regulatory requirements and mitigate organisational risks. Her experience encompasses the development of compliance policies; internal rules and procedures, coupled with comprehensive compliance training for organisational stakeholders.
Peace has a proven track record of providing corporate legal advisory services, particularly in ensuring compliance with Ugandan regulatory frameworks, including the Capital Markets Authority; Corporate Governance Regulations; Uganda Securities Exchange Listing Rules and the Company’s Act of Uganda. She is passionate about ensuring legal compliance and promoting ethical business practices within organisations, to drive sustainable growth and mitigate legal risks for clients.
Panda Ramakanta was appointed Head of Operation in 2023.
Prior to his appointment, he served as Head of Manufacturing in Cipla Quality chemical Industries since 2007 and Head of production in Cipla India since 2003.
Panda has 22 years of experience in core operations, with expertise in Green field projects , operation and Technology transfer. He posses strong leadership , product development , Quality management system skills.
He holds a bachelor’s degree in Pharmacy from Utkal University-India.
I am a seasoned sustainability and ESG executive with over 17 years of experience in both the public and private sectors. I am passionate about driving positive social and environmental impact while advancing business objectives. I have a proven ability to develop and execute sustainable strategies that create social value, improve environmental performance and save money. As an ESG executive, I am passionate about using the power of business to solve social and environmental challenges.
As the ESG Lead at Qcil, I am tasked with leading the development and implementation of the Company’s ESG strategy in line with the Company’s strategic focus. I also oversee the ESG reporting and disclosures process ensuring transparency and accountability in the company’s sustainability performance. Key to integrating sustainability considerations into business operations has been collaboration with cross functional teams, product development and supply chain management. Relatedly, I spearhead stakeholder engagement initiatives, partnerships with NGOs and Government Agencies and industry stakeholders to drive collective action on sustainability challenges.
My key skills and expertise include: ESG strategy development, ESG integration and reporting, stakeholder engagement and partnerships, corporate social responsibility, environmental management and compliance, and cross-functional leadership and collaboration.
I hold a post graduate degree in ESG and Sustainability from Wharton University of Pennsylvania, a diploma in Strategy and sustainability from IESE Business School in Spain, a diploma in Business planning and development and strategic thinking from Harvard Business School and a Bachelor’s degree in Social work and Social Administration from Makerere University Kampala.
My belief in lifelong learning and drawing inspiration from new experiences has shaped me into an avid reader across a variety of genres with an open mind and curious approach to life!
Mahadev Mandhare has 17 years of experience in Supply Chain Management with a unique blend of expertise in Procurement, Demand Planning, Supply Planning, Production Planning, Logistics, Material Planning, Warehousing, Distribution, and SAP Projects including but not limited to S4 HANA Implementation.
He joined Qcil in February 2023 as Head of Supply chain management. Previously, he worked at Cipla Ltd as a Cluster Head-material planning and at Encube-India as Head of planning. He delivered extraordinary results that drove organizational profitability, growth, and customer satisfaction.
He holds a PGDM degree in Supply Chain Management and a Batchelor of Science in Chemistry.
National Environment Sustainability Award for Exceptional Management of Active Chemicals (NEMA 2024)
Federation Of Uganda Employer Award For Disability Inclusion 2023
Outstanding Performance In Occupational Safety & Health Management For The Year 2023
Best Practices In Learning And Development - 2022 Survey
Employer Of The Year Award - 2021/22 Survey
Best Reward And Recognition Award - Prudential Best HR Practice Survey 2021
Financial Reporting Award - Fire Awards 2021
Indian Business Forum Award (Contribution Towards The Pharmaceutical/Health Sector: 2018)
Africa Award For Entrepreneurship (Transformational Business Of The Year: 2012)
Outstanding Achievement In Development Of The Pharmaceutical Sector (Ministry Of Health: 2012)
Investor Of The Year (Uganda Investment Authority: 2007)
Qcil aims to produce pharmaceutical products of the highest quality, that adhere strictly to cGMP and GLP, and numerous other international regulatory standards.
Qcil is one of the largest pharmaceutical manufacturers in East Africa and also one of the largest in SSA. Qcil is one of the few pharmaceutical manufacturers to operate a WHO cGMP-compliant facility, which manufactures a range of WHO pre-qualified medicines for treating HIV/AIDS and malaria.
Qcil has obtained ISO certifications for Environmental Management Systems (SO 14001:2015) and Occupational Health and Safety Management Systems (ISO 45001:2018). This helps Qcil promote better environmental management systems. We take pride in holding ourselves account
In December 2019, Qcil commissioned a
$10- million state-of-the-art quality control laboratory, which is double the size of the previous laboratory, accommodating more staff, and ensuring that the company is compliant with all safety and good laboratory practice requirements.The new facility has also helped to increase productivity and improve production timelines.
The new facility has also helped to increase productivity and improve production timelines.
Qcil constructed a new $5 million warehouse, with 3000 sqm, to increase in-house storage capacity and discontinue the use of third-party warehouses. The warehouse has been operational since January 2019 and has capacity for 5000 pallets.